Paper Details 
Original Abstract of the Article :
Studies were undertaken to evaluate the effectiveness of Acthar® Gel (repository corticotropin injection [RCI]) in the tetrodotoxin (TTX) model of early-life-induced epileptic spasms. Repository corticotropin injection (RCI) is widely used in the United States to treat infantile spasms. A major comp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/33548914

データ提供:米国国立医学図書館(NLM)

Acthar® Gel (Repository Corticotropin Injection) Dose-Response Relationships in an Animal Model of Epileptic Spasms

Infantile spasms, a severe form of epilepsy, are a challenging condition to treat. This research investigates the effectiveness of Acthar® Gel (repository corticotropin injection [RCI]), a medication commonly used for infantile spasms, in an animal model of epileptic spasms. The study aimed to determine the dose-response relationship of RCI in reducing spasm frequency and to explore the role of circulating corticosteroids in spasm cessation.

Effective at High Doses: RCI and Epileptic Spasm Suppression

The study found that RCI effectively suppressed spasms in rats at high dosages (24 or 32 IU/kg/day). Lower doses were ineffective. The researchers also observed that RCI significantly reduced hypsarrhythmia-like activity, an abnormal interictal EEG pattern associated with infantile spasms. These findings provide evidence for the efficacy of RCI in reducing spasm frequency and abnormal brain activity in this animal model.

Potential for Improved Treatment: Implications for Infantile Spasms

This research contributes to our understanding of the potential benefits of RCI in treating infantile spasms. The study highlights the importance of finding the appropriate dose of RCI to achieve maximal therapeutic effects. Further research is needed to confirm these findings in human clinical trials and to explore the potential for optimizing RCI treatment regimens for infantile spasms.

Dr. Camel's Conclusion

My dear friends, imagine a desert storm, a chaotic and relentless force that can leave a trail of destruction. This study is like a beacon of hope amidst the storm of infantile spasms, offering potential relief through the use of RCI. While more research is needed to fully understand the mechanisms of action and optimal dosing, the study provides valuable insights into the potential of RCI as a therapeutic agent for this debilitating condition. It's a reminder that even in the most challenging situations, there is always hope for a brighter future.
Date :
  1. Date Completed 2021-04-20
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

33548914

DOI: Digital Object Identifier

NIHMS1664462

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.